These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3569760)

  • 21. The influence of moderate hypoalbuminaemia on the renal metabolism and dynamics of furosemide in the rabbit.
    Pichette V; Geadah D; du Souich P
    Br J Pharmacol; 1996 Nov; 119(5):885-90. PubMed ID: 8922736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal effects of 2-chloroadenosine in the two-kidney Goldblatt rat.
    Churchill PC; Bidani AK; Churchill MC; Prada J
    J Pharmacol Exp Ther; 1984 Aug; 230(2):302-6. PubMed ID: 6379148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The renal actions of adenosine.
    Kövér G; Tost H
    Acta Physiol Hung; 1994; 82(3):215-28. PubMed ID: 7717084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired renal tubular potassium secretion in sickle cell disease.
    DeFronzo RA; Taufield PA; Black H; McPhedran P; Cooke CR
    Ann Intern Med; 1979 Mar; 90(3):310-16. PubMed ID: 34341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites.
    Clària J; Kent JD; López-Parra M; Escolar G; Ruiz-Del-Arbol L; Ginès P; Jiménez W; Vucelic B; Arroyo V
    Hepatology; 2005 Mar; 41(3):579-87. PubMed ID: 15723448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of neonatal capsaicin treatment on haemodynamics and renal function in cirrhotic rats.
    Li Y; Song D; Zhang Y; Lee SS
    Gut; 2003 Feb; 52(2):293-9. PubMed ID: 12524416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metamizole-furosemide interaction study in healthy volunteers.
    Rosenkranz B; Lehr KH; Mackert G; Seyberth HW
    Eur J Clin Pharmacol; 1992; 42(6):593-8. PubMed ID: 1623899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of furosemide on the hemodynamics of the kidney medulla during salt depletion].
    Heuer LJ; Menge B; Uthgenannt H
    Arzneimittelforschung; 1978; 28(6):1000-3. PubMed ID: 581995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of ibuprofen and indomethacin on renal function in the presence and absence of frusemide in healthy volunteers on a restricted sodium diet.
    Passmore AP; Copeland S; Johnston GD
    Br J Clin Pharmacol; 1990 Mar; 29(3):311-9. PubMed ID: 2178660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure.
    Goldsmith SR; Gilbertson DT; Mackedanz SA; Swan SK
    J Card Fail; 2011 Dec; 17(12):982-9. PubMed ID: 22123359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A(1) receptor blockade induces natriuresis with a favorable renal hemodynamic profile in SHHF/Mcc-fa(cp) rats chronically treated with salt and furosemide.
    Jackson EK; Kost CK; Herzer WA; Smits GJ; Tofovic SP
    J Pharmacol Exp Ther; 2001 Dec; 299(3):978-87. PubMed ID: 11714886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure.
    Costello-Boerrigter LC; Smith WB; Boerrigter G; Ouyang J; Zimmer CA; Orlandi C; Burnett JC
    Am J Physiol Renal Physiol; 2006 Feb; 290(2):F273-8. PubMed ID: 16189291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of OKY 046, a thromboxane-synthase inhibitor, on renal function in nonazotemic cirrhotic patients with ascites.
    Gentilini P; Laffi G; Meacci E; La Villa G; Cominelli F; Pinzani M; Buzzelli G
    Gastroenterology; 1988 Jun; 94(6):1470-7. PubMed ID: 3360268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of sodium intake, furosemide, and infusion of atrial natriuretic peptide on the urinary and metabolic clearances of arginine vasopressin in normal subjects.
    Moses AM; Jones C; Yucha CB
    J Clin Endocrinol Metab; 1990 Jan; 70(1):222-9. PubMed ID: 2136743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of peritoneovenous shunting in unravelling the pathogenesis of ascites in cirrhosis.
    Blendis LM
    Isr J Med Sci; 1986 Feb; 22(2):78-80. PubMed ID: 3512475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the effects of intravenous propranolol and nadolol on the renal response to hypertonic saline infusion.
    Waller DG; Mihindukulasuriya J; Warren DJ
    Br J Clin Pharmacol; 1985 Jan; 19(1):37-43. PubMed ID: 2858216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparing studies on the influence of dopamine and orciprenaline on cardiac and renal function of patients after cardiac surgery (author's transl)].
    Nadjmabadi MH; Purschke R; Tarbiat S; Lennartz H; Bircks W
    Thoraxchir Vask Chir; 1975 Dec; 23(6):552-9. PubMed ID: 1082662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of furosemide-induced natriuresis by acetylsalicylic acid in dogs.
    Berg KJ; Loew D
    Scand J Clin Lab Invest; 1977 Apr; 37(2):125-31. PubMed ID: 616038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal hemodynamics in patients with sustained essential hypertension and in patients with unilateral stenosis of the renal artery.
    London GM; Safar ME
    Am J Hypertens; 1989 Apr; 2(4):244-52. PubMed ID: 2706091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal perfusion in dogs with experimental hepatic cirrhosis: role of prostaglandins.
    Levy M; Wexler MJ; Fechner C
    Am J Physiol; 1983 Oct; 245(4):F521-9. PubMed ID: 6353940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.